MENU
+Compare
LLY
Stock ticker: NYSE
AS OF
Jul 10, 04:59 PM (EDT)
Price
$790.54
Change
+$3.62 (+0.46%)
Capitalization
739.66B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology... Show more

LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LLY with price predictions
Jul 09, 2025

LLY in upward trend: 10-day moving average broke above 50-day moving average on July 03, 2025

The 10-day moving average for LLY crossed bullishly above the 50-day moving average on July 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where LLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 07, 2025. You may want to consider a long position or call options on LLY as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

LLY moved above its 50-day moving average on July 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 362 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 328 cases where LLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LLY moved out of overbought territory on June 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for LLY turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LLY broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (67.114) is very high in comparison to the industry average of (5.632). P/E Ratio (131.129) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.440) is also within normal values, averaging (3.004). Dividend Yield (0.006) settles around the average of (0.161) among similar stocks. LLY's P/S Ratio (20.121) is very high in comparison to the industry average of (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LLY is expected to report earnings to rise 66.77% to $5.57 per share on August 07

Eli Lilly & Co LLY Stock Earnings Reports
Q2'25
Est.
$5.57
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.27
Q2'24
Beat
by $1.18
The last earnings report on May 01 showed earnings per share of $3.34, missing the estimate of $3.46. With 3.11M shares outstanding, the current market capitalization sits at 739.66B.
A.I.Advisor
published Dividends

LLY paid dividends on June 10, 2025

Eli Lilly & Co LLY Stock Dividends
А dividend of $1.50 per share was paid with a record date of June 10, 2025, and an ex-dividend date of May 16, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
43000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSPD56.000.65
+1.17%
Invesco S&P 500® Equal Wt Cnsm Disc ETF
CGDV40.710.29
+0.72%
Capital Group Dividend Value ETF
ACP5.970.04
+0.67%
abrdn Income Credit Strategies Fund
FLQS42.160.13
+0.30%
Franklin US Small Cap Mltfctr Idx ETF
TINT30.57N/A
N/A
ProShares Smart Materials ETF

LLY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.47%
AZN - LLY
45%
Loosely correlated
+1.40%
NVS - LLY
42%
Loosely correlated
+0.64%
OGN - LLY
40%
Loosely correlated
+1.11%
MRK - LLY
32%
Poorly correlated
+0.37%
PFE - LLY
32%
Poorly correlated
+0.86%
More